Atossa Therapeutics, Inc. Information Request Form
Company: Atossa Therapeutics, Inc.
NASDAQ: ATOS
Levi & Korsinsky announces it has commenced an investigation of Atossa Therapeutics, Inc. (NASDAQ: ATOS) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.